D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 2, 2024

Primary Completion Date

January 2, 2026

Study Completion Date

January 2, 2030

Conditions
Blood LossIntensive CareAnastomotic LeakageLymph Node DiseaseSurvivalBlood Transfusion
Interventions
PROCEDURE

LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (intervention)

Patients with right-side colon cancer (caecum, ascending, or hepatic flexure); were diagnosed by CT entero-colonography, colonoscopy, and biopsy who undergo laparoscopic right hemicolectomy

DRUG

Enoxaparin 40 Mg/0.4 mL Injectable Solution

Enoxaparin sodium 40 mg subcutaneous injection will be administered 12 hours before the operation

DRUG

Levofloxacin 500mg

Levofloxacin 500 mg intravenous injection will be administered 1 hour before the operation.

PROCEDURE

LAPAROSCOPIC RIGHT HEMICOLECTOMY procedure (Conventional)

Patients with right-side colon cancer (caecum, ascending, or hepatic flexure); were diagnosed by CT entero-colonography, colonoscopy, and biopsy who undergo laparoscopic right hemicolectomy

Trial Locations (1)

Unknown

The surgical department of Medical Research Institute Hospital, Alexandria University, Alexandria

All Listed Sponsors
lead

General Committee of Teaching Hospitals and Institutes, Egypt

OTHER_GOV

NCT06049758 - D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy | Biotech Hunter | Biotech Hunter